- Home
- REE vs TXMD Comparison
REE vs TXMD Comparison
Compare REE & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REE | TXMD |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7M | 21.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REE | TXMD |
|---|---|---|
| Price | $0.75 | $1.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.75 | N/A |
| AVG Volume (30 Days) | ★ 109.4K | 54.8K |
| Earning Date | 12-17-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | $183,000.00 | ★ $2,796,000.00 |
| Revenue This Year | $327.73 | $427.09 |
| Revenue Next Year | $36,888.82 | N/A |
| P/E Ratio | ★ N/A | $259.70 |
| Revenue Growth | N/A | ★ 75.19 |
| 52 Week Low | $0.53 | $0.70 |
| 52 Week High | $10.24 | $2.44 |
Technical Indicators
Market Signals| Indicator | REE | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 53.59 |
| Support Level | $0.65 | $1.64 |
| Resistance Level | $0.82 | $1.83 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 62.99 | 44.14 |
Price Performance
Historical ComparisonAbout REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.